Production (Stage)
Thermo Fisher Scientific Inc.
TMO
$393.66
-$6.82-1.70%
NYSE
| 03/29/2025 | 12/31/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.96% | 0.05% | -2.42% | -2.71% | -3.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.96% | 0.05% | -2.42% | -2.71% | -3.00% |
| Cost of Revenue | -0.53% | -2.07% | -3.78% | -4.33% | -3.30% |
| Gross Profit | 3.14% | 3.22% | -0.38% | -0.26% | -2.57% |
| SG&A Expenses | 0.72% | 2.55% | 0.57% | -2.11% | -3.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 2,900.00% | 2,900.00% | -- | -- | -- |
| Total Operating Expenses | 0.10% | -0.67% | -2.77% | -3.95% | -3.64% |
| Operating Income | 4.98% | 3.45% | -0.76% | 3.49% | 0.11% |
| Income Before Tax | 7.32% | 12.17% | 8.26% | 12.51% | 0.52% |
| Income Tax Expenses | -9.06% | 131.69% | 97.84% | 97.02% | 15.85% |
| Earnings from Continuing Operations | 8.74% | 6.47% | 3.36% | 8.05% | -0.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -110.26% | -110.00% | -22.22% | 780.00% | 587.50% |
| Net Income | 7.97% | 5.69% | 3.28% | 8.74% | 0.17% |
| EBIT | 4.98% | 3.45% | -0.76% | 3.49% | 0.11% |
| EBITDA | -0.31% | -0.37% | -2.49% | 1.62% | 0.09% |
| EPS Basic | 9.19% | 6.87% | 4.36% | 10.02% | 1.48% |
| Normalized Basic EPS | 6.08% | 7.00% | 2.54% | 8.81% | 4.73% |
| EPS Diluted | 9.36% | 6.99% | 4.69% | 10.37% | 1.79% |
| Normalized Diluted EPS | 6.21% | 7.06% | 2.67% | 9.01% | 4.85% |
| Average Basic Shares Outstanding | -1.10% | -1.10% | -1.03% | -1.16% | -1.28% |
| Average Diluted Shares Outstanding | -1.23% | -1.16% | -1.16% | -1.34% | -1.40% |
| Dividend Per Share | 11.11% | 11.43% | 12.59% | 13.85% | 15.20% |
| Payout Ratio | 0.02% | 0.05% | 0.10% | 0.05% | 0.15% |